05 January 2004 00:00 [Source: ICB Americas]Invitrogen Corp. has signed a definitive agreement to acquire BioReliance Corp., for about $500 million, including the assumption of roughly $70 million in debt. A contract service organization based in Rockville, Md., BioReliance provides testing, development and manufacturing services for biologic-based drugs.
GFS Chemicals Inc., based in Powell, Ohio, will complete a state-of-the-art dry room in early 2004. Featuring inert gas blanketing and temperature and atmospheric controls to a relative humidity of less than 1 percent and a dew point under -45ûF, the facility can accommodate a wide range of moisture- and temperature-sensitive materials.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.